Abstract:Background: Neural Precursor Cell Expressed Developmentally Down-Regulated Protein 1 (NEDD1) serves as a crucial factor in promoting cellular mitosis by directly facilitating wheel assembly and daughter centriole biogenesis at the lateral site of parent centrioles, ultimately driving centrosome replication. The amplification of centrosomes and the abnormal expression of centrosome-associated proteins contribute to the invasion and metastasis of non-small cell lung cancer cells. However, the specific mechanism by which NEDD1 contributes to the progression of lung adenocarcinoma (LUAD) remains unexplored. Therefore, the objective of this study is to uncover the role played by NEDD1 in LUAD. Methods: To verify the expression of NEDD1 in pan-carcinoma. The feasibility of NEDD1 as a prognostic marker for LUAD in TCGA and GEO databases was verified. Subsequently, Cox proportional hazard regression analysis was used to screen the prognostic factors of LUAD, so as to analyze the correlation between prognostic factors and NEDD1 expression. For another, NEDD1-related genes were screened for pathway enrichment analysis to verify their possible functions. In addition, the expression of NEDD1 in LUAD was verified by qPCR and IHC, then siRNA was used to construct NEDD1-knocked lung cancer cells for subsequent cytobehavioral experiments. Finally, the distribution of NEDD1 in single-cell samples was revealed, and then the correlation between its overexpression and LUAD immune escape and drug resistance was analyzed. Results: LUAD exhibits upregulation of NEDD1, which in turn promotes the proliferation, migration, invasion, and epithelial-mesenchymal transition of lung cancer cells, thereby contributing to a poor prognosis. Furthermore, the overexpression of NEDD1 is closely associated with immune escape and drug resistance in LUAD. Conclusion: NEDD1 serves as a reliable prognostic marker for LUAD, and its upregulation is associated with increased immune escape and drug resistance. Given these findings, NEDD1 holds potential as a novel therapeutic target for the treatment of LUAD.

Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma

Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma

NEDD1 overexpression increases cell proliferation, tumor immune escape, and drug resistance in LUAD

NEDD1 Promotes the Development of Lung Adenocarcinoma and Can be Used as a Prognostic Marker

NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor

Overactivated neddylation pathway as a therapeutic target in lung cancer

Neddylation pathway promotes myeloid-derived suppressor cell infiltration via NF-κB-mCXCL5 signaling in lung cancer

NEDD4L Suppresses Proliferation and Promotes Apoptosis by Ubiquitinating RAC2 Expression and Acts as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma

The NEDD8-activating enzyme E1 UBA3 orchestrates the immunosuppressive microenvironment in lung adenocarcinoma via the NF-кB pathway

Expression and regulatory network of E3 ubiquitin ligase NEDD4 family in cancers

Overexpression of NEDD9 is Associated with Altered Expression of E-Cadherin, Β-Catenin and N-Cadherin and Predictive of Poor Prognosis in Non-Small Cell Lung Cancer.

Insights Into the Biological Role of NEDD4L E3 Ubiquitin Ligase in Human Cancers

NEDD4 E3 ligase: Functions and mechanism in human cancer

Supplementary Figures 1-12 from the CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway

Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer

Data from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by <i>LKB1</i> Loss

The Crtc1-Nedd9 Signaling Axis Mediates Lung Cancer Progression Caused By Lkb1 Loss

Nedd9 Promotes Lung Cancer Metastasis Through Epithelial- Mesenchymal Transition

Inhibition of NEDD4 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis in Bladder Cancer Cells.

Neddylation Pattern Indicates Tumor Microenvironment Characterization and Predicts Prognosis in Lung Adenocarcinoma.